HoneyBear Biosciences, Inc
HoneyBear Biosciences, Inc. is a Taiwan-based biotech company focused on developing innovative antibody-drug conjugates (ADCs) to improve therapeutic outcomes for cancer patients. The company utilizes its proprietary Co-Nectar® platform for site-specific conjugation of antibodies to create novel ADCs.